BioUtah News

ARUP Researchers’ Prolific Publications, Presentations Helped Advance Lab Medicine in 2021

Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of…
PolarityTE Announces Allowance of Fourth U.S. Patent

PolarityTE, Inc. announced the U.S. Patent and Trademark Office (USPTO) recently issued a Notice of Allowance for U.S.…
ARUP Laboratories Is Ranked Among America’s Best Midsize Employers by Forbes

ARUP’s commitment to creating a satisfying work environment for employees has earned it a spot on Forbes’ list…
Nexus Spine Appoints Steve Cichy as Vice President of Sales

Appointment further expands leadership team to support aggressive commercialization of the company’s PressON™ fixation, Tranquil™ interbody, and pending…
Epitel Secures $12.5 Million Series A Financing for Wearable, Wireless EEG Monitoring System

FDA-Cleared REMI Platform to Begin Initial Commercialization to Hospitals for Use in Emergency Departments and Intensive Care Units…
IONIQ Sciences 2021 Year-End Update

Originally published by IONIQ Sciences Dear IONIQ Sciences Shareholders and Friends, Greetings from IONIQ Sciences where we continue to…
Stanford Researchers cite BioPharm Laboratories High Purity Thrombin

BioPharm Laboratories, another journal article from the Journal of Biological Chemistry cites the use of BioPharm’s High Purity…
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load Test

SALT LAKE CITY, Feb. 3, 2022 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with…
Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State Capital

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development…
Nelson Labs Launches Verification Program to Help Consumers Identify Properly Tested Masks and Respirators

New Nelson Labs Mark offers transparency and confidence in product testing
IONIQ Sciences submits De Novo application to FDA for IONIQ ProLung Test

Salt Lake City, UT, February 2, 2022 – IONIQ Sciences, Inc. (“IONIQ” or the “Company”) announced today that…
Fluidx Medical’s Embolic Demonstrates Novel Visibility Advantage

Fluidx Medical Reports Initial Research on First-of-its-Kind Embolic Agent with Intermediate Radiopacity